Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Imaging And Path LabBOM:544482 -2.22%21 Interest Coverage is 19.30 as of Mar. 2026, which is 133% above its 10-year median of 8.27. GuruFocus rates BOM:544482 with a GF Score™ of 21/100. Among 92 Medical Diagnostics & Research companies, Star Imaging And Path Lab ranks better than 57.61% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Star Imaging And Path Lab's
Operating Income
for the
six
months ended in Mar. 2026 was ₹128.1 Mil. Star Imaging And Path Lab's Interest Expense for the
six
months ended in Mar. 2026 was ₹-6.6 Mil.
Star Imaging And Path Lab's interest coverage for the quarter that ended in Mar. 2026 was 19.30.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Star Imaging And Path Lab's Interest Coverage or its related term are showing as below:
BOM:544482'
s Interest Coverage Range Over the Past 10 Years
Min: 1.24 Med: 8.27 Max: 14.84
Current: 13.87
BOM:544482's Interest Coverage is ranked better than 57.61% of 92
companies
in the Medical Diagnostics & Research industry
Industry Median: 9.61
vs BOM:544482: 13.87
Star Imaging And Path Lab (BOM:544482) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Star Imaging And Path Lab Interest Coverage Related Terms
Star Imaging And Path Lab Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:544482 vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Star Imaging And Path Lab's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Imaging And Path Lab Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Star Imaging And Path Lab's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Star Imaging And Path Lab's Interest Coverage falls into.
Star Imaging And Path Lab Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Imaging And Path Lab (BOM:544482) has a Interest Coverage of 19.30 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Star Imaging And Path Lab and its competitors. This is 133% above median its historical median of 8.27. Over the past decade, Star Imaging And Path Lab's Interest Coverage has ranged from 1.24 to 14.84. According to the industry distribution chart, Star Imaging And Path Lab ranks #39 out of 92 companies in the Medical Diagnostics & Research industry, placing it in the top 42.4%.
Is Star Imaging And Path Lab's Interest Coverage too high?
Star Imaging And Path Lab's current Interest Coverage of 19.30 is 133% above median its 10-year median of 8.27. Over the past 10 years, this metric has ranged from a low of 1.24 to a high of 14.84. The Medical Diagnostics & Research industry median Interest Coverage is 9.61. Star Imaging And Path Lab's value of 19.30 is 100.8% above this industry median. Based on the distribution chart, Star Imaging And Path Lab ranks #39 out of 92 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Star Imaging And Path Lab has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Star Imaging And Path Lab's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Star Imaging And Path Lab ranks #39 out of 92 companies for Interest Coverage. This puts Star Imaging And Path Lab in the upper half of its industry. The industry median Interest Coverage is 9.61. Star Imaging And Path Lab's value of 19.30 is 100.8% above this benchmark. Historically, Star Imaging And Path Lab's own Interest Coverage has ranged from 1.24 to 14.84 over the past decade. While the company's 10-year median is 8.27 vs. the industry median of 9.61, Star Imaging And Path Lab has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.61, based on 92 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Imaging And Path Lab's current Interest Coverage of 19.30 is 100.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Star Imaging And Path Lab and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Imaging And Path Lab's current Interest Coverage is 19.30, which is 133% above median its own 10-year median of 8.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Imaging And Path Lab stock overvalued right now?
Star Imaging And Path Lab (BOM:544482) has a current Interest Coverage of 19.30. The current Interest Coverage is 19.30, which is 133% above median its 10-year median of 8.27 and 100.8% above the Medical Diagnostics & Research industry median of 9.61. Star Imaging And Path Lab's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Star Imaging And Path Lab (BOM:544482), the current Interest Coverage is 19.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Star Imaging And Path Lab Ltd operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi and Uttar Pradesh. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. The company's diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography.
21GF Score
Get the complete analysis for BOM:544482
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544482 has been successfully added to your 
